{"protocolSection": {"identificationModule": {"nctId": "NCT01932606", "orgStudyIdInfo": {"id": "13-004077"}, "organization": {"fullName": "Mayo Clinic", "class": "OTHER"}, "briefTitle": "Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction", "officialTitle": "Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction"}, "statusModule": {"statusVerifiedDate": "2016-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2013-08"}, "primaryCompletionDateStruct": {"date": "2014-10", "type": "ACTUAL"}, "completionDateStruct": {"date": "2014-10", "type": "ACTUAL"}, "studyFirstSubmitDate": "2013-08-27", "studyFirstSubmitQcDate": "2013-08-29", "studyFirstPostDateStruct": {"date": "2013-08-30", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2016-01-15", "resultsFirstSubmitQcDate": "2016-01-18", "resultsFirstPostDateStruct": {"date": "2016-02-15", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2016-02-15", "lastUpdatePostDateStruct": {"date": "2016-03-14", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR_INVESTIGATOR", "investigatorFullName": "Barry Borlaug", "investigatorTitle": "M.D., Associate Professor of Medicine", "investigatorAffiliation": "Mayo Clinic"}, "leadSponsor": {"name": "Barry Borlaug", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Heart failure with preserved ejection fraction (HFpEF) is a major public health problem that has no proven effective treatment. This study assessed the effects of acute nitrite administration on resting and exercise hemodynamics in patients with HFpEF.", "detailedDescription": "Subjects were studied on their long-term medications in the post-absorptive state and supine position. Right heart catheterization was performed with simultaneous expired gas analysis at rest and during supine exercise at a 20 Watts workload for 5 minutes. After the first exercise phase (before any drug administration) and after return to steady-state baseline hemodynamic values, subjects were randomized. Study drug or placebo was infused for 5 minutes. After a 10 minute observation period, hemodynamic measurements were repeated at rest, followed by repeat supine exercise at a 20 Watts workload for 5 minutes, identical to the study's first phase. Arterial and venous blood samples and hemodynamic and expired gas data were acquired during each stage of the protocol."}, "conditionsModule": {"conditions": ["Heart Disease", "Heart Failure With Preserved Ejection Fraction", "Exercise Intolerance", "Pulmonary Hypertension"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 28, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Nitrite", "type": "EXPERIMENTAL", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.", "interventionNames": ["Drug: Nitrite"]}, {"label": "Saline", "type": "PLACEBO_COMPARATOR", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.", "interventionNames": ["Drug: Saline Placebo for Nitrite"]}], "interventions": [{"type": "DRUG", "name": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.", "armGroupLabels": ["Nitrite"]}, {"type": "DRUG", "name": "Saline Placebo for Nitrite", "description": "Normal saline placebo will be infused for 5 minutes during the cardiac catheterization procedure. Hemodynamics will then be measured at baseline after study drug infusion and again during low level exercise (20 Watts).", "armGroupLabels": ["Saline"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Exercise Pulmonary Capillary Wedge Pressure (PCWP)", "description": "Pulmonary capillary wedge pressure (PCWP) provides an indirect estimate of left atrial pressure (LAP). PCWP is the pressure measured by wedging a pulmonary catheter with an inflated balloon into a small pulmonary arterial branch.", "timeFrame": "during repeat exercise run, approximately 30 minutes after study drug administration"}], "secondaryOutcomes": [{"measure": "Change in Central Pressures After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.)", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Heart Rate After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.)", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Blood Pressure After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.)", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Pulmonary Vascular Resistance (PVR) After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Pulmonary Vascular Resistance (PVR) is the resistance to flow that must be overcome to push blood through the pulmonary vasculature. Acute and chronic lung disease can both cause an increase in PVR. Chronic PVR can lead to right sided heart failure.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Pulmonary Artery (PA) Compliance After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Pulmonary artery compliance is an index of the elasticity of the blood vessel, an indication of arterial stiffness.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Systemic Vascular Resistance (SVR) After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Systemic vascular resistance (SVR) refers to the resistance to blood flow offered by all of the systemic vasculature, excluding the pulmonary vasculature.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Left Ventricular Stroke Work (LVSW) After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Stroke work refers to the work done by the ventricle to eject a volume of blood (i.e., stroke volume) into the aorta. Ventricular stroke work can be estimated as the product of stroke volume and mean aortic pressure during ejection.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Oxygen Consumption (VO_2) After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.)", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Arteriovenous Oxygen Content Difference After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Arteriovenous oxygen difference is the difference in the oxygen content of the blood between the arterial blood and the venous blood. It is an indication of how much oxygen is removed from the blood in capillaries as the blood circulates in the body.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Cardiac Output After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) The volume of blood pumped per minute by each ventricle of the heart. Cardiac output is equal to the stroke volume (the amount of blood pumped from a ventricle in a single heartbeat) times the heart rate.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Stroke Volume After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Stroke volume is the amount of blood pumped out of the heart (left ventricle - to the body) during each contraction.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Central Pressures After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Heart Rate After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Blood Pressure After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in PVR After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Pulmonary Vascular Resistance (PVR) is the resistance to flow that must be overcome to push blood through the pulmonary vasculature. Acute and chronic lung disease can both cause an increase in PVR. Chronic PVR can lead to right sided heart failure.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in PA Compliance After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Pulmonary artery compliance is an index of the elasticity of the blood vessel, an indication of arterial stiffness.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in SVR After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Systemic vascular resistance (SVR) refers to the resistance to blood flow offered by all of the systemic vasculature, excluding the pulmonary vasculature.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in LVSW After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Stroke work refers to the work done by the ventricle to eject a volume of blood (i.e., stroke volume) into the aorta. Ventricular stroke work can be estimated as the product of stroke volume and mean aortic pressure during ejection.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Oxygen Consumption (VO_2) After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Arteriovenous Oxygen Difference After Study Drug (Exercise)", "description": "Arteriovenous oxygen difference is the difference in the oxygen content of the blood between the arterial blood and the venous blood. It is an indication of how much oxygen is removed from the blood in capillaries as the blood circulates in the body.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Cardiac Output After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Cardiac output is equal to the stroke volume (the amount of blood pumped from a ventricle in a single heartbeat) times the heart rate.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}, {"measure": "Change in Stroke Volume After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Stroke volume is the amount of blood pumped out of the heart (left ventricle - to the body) during each contraction.", "timeFrame": "baseline, approximately 30 minutes after study drug administration"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Scheduled to undergo a cardiac catheterization procedure.\n* Clinical symptoms of shortness of breath and fatigue\n* Normal left ventricular ejection fraction (\u226550%)\n* Elevated left ventricular filling pressures at cardiac catheterization (defined as resting pulmonary capillary wedge pressure (PCWP)\\>15 mmHg and/or PCWP\u226525 mmHg during exercise)\n\nExclusion Criteria:\n\n* Systolic BP \\<120 mmHg\n* Prior nitrate therapy (within previous 2 weeks)\n* Glucose 6-phosphate dehydrogenase (G6PD) deficiency\n* Other \"non-HFpEF\" specific causes of heart failure such as significant valvular disease (\\>moderate left-sided regurgitation, \\>mild stenosis), severe pulmonary disease, unstable coronary disease or coronary spasm, primary renal or hepatic disease, constrictive pericarditis, or infiltrative, restrictive, or hypertrophic cardiomyopathies", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Barry Borlaug, MD", "affiliation": "Mayo Clinic", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Mayo Clinic in Rochester", "city": "Rochester", "state": "Minnesota", "zip": "55905", "country": "United States", "geoPoint": {"lat": 44.02163, "lon": -92.4699}}]}, "referencesModule": {"references": [{"pmid": "26449137", "type": "RESULT", "citation": "Borlaug BA, Koepp KE, Melenovsky V. Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2015 Oct 13;66(15):1672-82. doi: 10.1016/j.jacc.2015.07.067."}, {"pmid": "33421267", "type": "DERIVED", "citation": "Reddy YNV, Stewart GM, Obokata M, Koepp KE, Borlaug BA. Peripheral and pulmonary effects of inorganic nitrite during exercise in heart failure with preserved ejection fraction. Eur J Heart Fail. 2021 May;23(5):814-823. doi: 10.1002/ejhf.2093. Epub 2021 Feb 1."}]}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "Subjects were enrolled in the trial between January and September 2014.", "groups": [{"id": "FG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "FG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "14"}, {"groupId": "FG001", "numSubjects": "14"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "14"}, {"groupId": "FG001", "numSubjects": "14"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "BG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "28"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "69", "spread": "6"}, {"groupId": "BG001", "value": "70", "spread": "8"}, {"groupId": "BG002", "value": "69", "spread": "8"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "17"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "11"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "28"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Exercise Pulmonary Capillary Wedge Pressure (PCWP)", "description": "Pulmonary capillary wedge pressure (PCWP) provides an indirect estimate of left atrial pressure (LAP). PCWP is the pressure measured by wedging a pulmonary catheter with an inflated balloon into a small pulmonary arterial branch.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "during repeat exercise run, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "19.0", "spread": "5.0"}, {"groupId": "OG001", "value": "28.0", "spread": "6.0"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0003", "statisticalMethod": "ANCOVA", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Central Pressures After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"title": "Right atrial pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2", "spread": "2"}, {"groupId": "OG001", "value": "0", "spread": "1"}]}]}, {"title": "Pulmonary artery systolic pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "-8", "spread": "5"}, {"groupId": "OG001", "value": "-3", "spread": "4"}]}]}, {"title": "Mean pulmonary artery pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "-6", "spread": "3"}, {"groupId": "OG001", "value": "-1", "spread": "3"}]}]}, {"title": "PCWP", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3", "spread": "3"}, {"groupId": "OG001", "value": "0", "spread": "1"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in right atrial pressure.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0003", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in pulmonary artery systolic pressure.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.01", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in mean pulmonary artery pressure.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.002", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the 2 arms for change in PCWP.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Heart Rate After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "beats/minute", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "5"}, {"groupId": "OG001", "value": "-3", "spread": "5"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.15", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Blood Pressure After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"title": "Systolic Blood Pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "-7", "spread": "8"}, {"groupId": "OG001", "value": "-2", "spread": "10"}]}]}, {"title": "Mean Blood Pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3", "spread": "4"}, {"groupId": "OG001", "value": "-1", "spread": "6"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in systolic blood pressure.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.11", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in mean blood pressure.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.2", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Pulmonary Vascular Resistance (PVR) After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Pulmonary Vascular Resistance (PVR) is the resistance to flow that must be overcome to push blood through the pulmonary vasculature. Acute and chronic lung disease can both cause an increase in PVR. Chronic PVR can lead to right sided heart failure.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg/L/min", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "0.4"}, {"groupId": "OG001", "value": "-0.4", "spread": "0.6"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in PVR.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.7", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Pulmonary Artery (PA) Compliance After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Pulmonary artery compliance is an index of the elasticity of the blood vessel, an indication of arterial stiffness.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/mm Hg", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "1.3"}, {"groupId": "OG001", "value": "0.2", "spread": "0.6"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in pulmonary artery compliance.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.1", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Systemic Vascular Resistance (SVR) After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Systemic vascular resistance (SVR) refers to the resistance to blood flow offered by all of the systemic vasculature, excluding the pulmonary vasculature.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "dyne/s * cm^5", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "140", "spread": "350"}, {"groupId": "OG001", "value": "20", "spread": "160"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in SVR.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.3", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Left Ventricular Stroke Work (LVSW) After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Stroke work refers to the work done by the ventricle to eject a volume of blood (i.e., stroke volume) into the aorta. Ventricular stroke work can be estimated as the product of stroke volume and mean aortic pressure during ejection.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "g/beat", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-6", "spread": "18"}, {"groupId": "OG001", "value": "0", "spread": "9"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in LVSW.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.3", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Oxygen Consumption (VO_2) After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/min", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-2", "spread": "38"}, {"groupId": "OG001", "value": "-6", "spread": "15"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in VO_2.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.8", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Arteriovenous Oxygen Content Difference After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Arteriovenous oxygen difference is the difference in the oxygen content of the blood between the arterial blood and the venous blood. It is an indication of how much oxygen is removed from the blood in capillaries as the blood circulates in the body.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/dl", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.4", "spread": "0.5"}, {"groupId": "OG001", "value": "0", "spread": "0.4"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for arteriovenous oxygen content difference.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.1", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Cardiac Output After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) The volume of blood pumped per minute by each ventricle of the heart. Cardiac output is equal to the stroke volume (the amount of blood pumped from a ventricle in a single heartbeat) times the heart rate.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "L/min", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.4", "spread": "0.8"}, {"groupId": "OG001", "value": "-0.2", "spread": "0.5"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in cardiac output.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.4", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Stroke Volume After Study Drug (Resting)", "description": "Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Stroke volume is the amount of blood pumped out of the heart (left ventricle - to the body) during each contraction.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-5", "spread": "16"}, {"groupId": "OG001", "value": "-1", "spread": "9"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in stroke volume.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.4", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Central Pressures After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"title": "Right atrial pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5", "spread": "2"}, {"groupId": "OG001", "value": "-1", "spread": "2"}]}]}, {"title": "Pulmonary artery systolic pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "-11", "spread": "6"}, {"groupId": "OG001", "value": "-4", "spread": "8"}]}]}, {"title": "Mean pulmonary artery pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "10", "spread": "4"}, {"groupId": "OG001", "value": "-2", "spread": "5"}]}]}, {"title": "PCWP", "categories": [{"measurements": [{"groupId": "OG000", "value": "-11", "spread": "5"}, {"groupId": "OG001", "value": "-2", "spread": "5"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in right atrial pressure (exercise).", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0002", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in pulmonary artery systolic pressure (exercise).", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.01", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in mean pulmonary artery pressure (exercise).", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0002", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in PCWP (exercise).", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0002", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Heart Rate After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "beats/minute", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-1", "spread": "6"}, {"groupId": "OG001", "value": "0", "spread": "3"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in heart rate.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.3", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Blood Pressure After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"title": "Systolic Blood Pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5", "spread": "13"}, {"groupId": "OG001", "value": "2", "spread": "10"}]}]}, {"title": "Diastolic Blood Pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5", "spread": "8"}, {"groupId": "OG001", "value": "0", "spread": "2"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in systolic blood pressure.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.2", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in diastolic blood pressure.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.05", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in PVR After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Pulmonary Vascular Resistance (PVR) is the resistance to flow that must be overcome to push blood through the pulmonary vasculature. Acute and chronic lung disease can both cause an increase in PVR. Chronic PVR can lead to right sided heart failure.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg/L/min", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.4"}, {"groupId": "OG001", "value": "0.2", "spread": "0.4"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in PVR after study drug (exercise)", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.3", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in PA Compliance After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Pulmonary artery compliance is an index of the elasticity of the blood vessel, an indication of arterial stiffness.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/mm Hg", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "0.9"}, {"groupId": "OG001", "value": "0.5", "spread": "0.9"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in PA compliance after study drug (exercise)", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.3", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in SVR After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Systemic vascular resistance (SVR) refers to the resistance to blood flow offered by all of the systemic vasculature, excluding the pulmonary vasculature.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "dyne/s * cm^5", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-70", "spread": "140"}, {"groupId": "OG001", "value": "70", "spread": "100"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in SVR after study drug (exercise).", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.007", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in LVSW After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Stroke work refers to the work done by the ventricle to eject a volume of blood (i.e., stroke volume) into the aorta. Ventricular stroke work can be estimated as the product of stroke volume and mean aortic pressure during ejection.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "g/beat", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "15", "spread": "12"}, {"groupId": "OG001", "value": "-2", "spread": "8"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in LVSW after study drug (exercise)", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0003", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Oxygen Consumption (VO_2) After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/min", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "70", "spread": "138"}, {"groupId": "OG001", "value": "-30", "spread": "67"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in oxygen consumption (VO_2) after study drug (exercise).", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.02", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Arteriovenous Oxygen Difference After Study Drug (Exercise)", "description": "Arteriovenous oxygen difference is the difference in the oxygen content of the blood between the arterial blood and the venous blood. It is an indication of how much oxygen is removed from the blood in capillaries as the blood circulates in the body.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml/dl", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.2", "spread": "0.4"}, {"groupId": "OG001", "value": "0", "spread": "0.6"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in arteriovenous oxygen difference after study drug (exercise).", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.6", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Cardiac Output After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Cardiac output is equal to the stroke volume (the amount of blood pumped from a ventricle in a single heartbeat) times the heart rate.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "L/min", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.5", "spread": "0.7"}, {"groupId": "OG001", "value": "-0.4", "spread": "0.7"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in cardiac output after study drug (exercise).", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.002", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}, {"type": "SECONDARY", "title": "Change in Stroke Volume After Study Drug (Exercise)", "description": "Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Stroke volume is the amount of blood pumped out of the heart (left ventricle - to the body) during each contraction.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ml", "timeFrame": "baseline, approximately 30 minutes after study drug administration", "groups": [{"id": "OG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure."}, {"id": "OG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "7", "spread": "8"}, {"groupId": "OG001", "value": "-5", "spread": "6"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Comparison between the arms for change in stroke volume after study drug (exercise).", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0002", "statisticalMethod": "t-test, 2 sided", "ciNumSides": "TWO_SIDED"}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Subjects will be followed for adverse event reporting during the procedure and the recovery period, approximately 3 hours after the procedure on Day 1.", "eventGroups": [{"id": "EG000", "title": "Nitrite", "description": "Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.", "seriousNumAffected": 0, "seriousNumAtRisk": 14, "otherNumAffected": 0, "otherNumAtRisk": 14}, {"id": "EG001", "title": "Placebo", "description": "Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.", "seriousNumAffected": 0, "seriousNumAtRisk": 14, "otherNumAffected": 0, "otherNumAtRisk": 14}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Dr. Barry A. Borlaug", "organization": "Mayo Clinic", "email": "Borlaug.Barry@mayo.edu", "phone": "507-284-6704"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006976", "term": "Hypertension, Pulmonary"}, {"id": "D000006333", "term": "Heart Failure"}, {"id": "D000006331", "term": "Heart Diseases"}], "ancestors": [{"id": "D000006973", "term": "Hypertension"}, {"id": "D000014652", "term": "Vascular Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}], "browseLeaves": [{"id": "M10024", "name": "Hypertension", "relevance": "LOW"}, {"id": "M9419", "name": "Heart Diseases", "asFound": "Heart Disease", "relevance": "HIGH"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M10027", "name": "Hypertension, Pulmonary", "asFound": "Pulmonary Hypertension", "relevance": "HIGH"}, {"id": "M17400", "name": "Vascular Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "T170", "name": "Acute Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}}, "hasResults": true}